Remnant Cholesterol as a Residual Risk in Patients With Atherosclerotic Cardiovascular Disease Under ModerateIntensity Statin With Ezetimibe Combination Therapy or HighIntensity Statin Monotherapy

被引：0
|
作者：
Lee, Jung-Hee [1 ]
Ahn, Sung Gyun [2 ]
Lee, Seung-Jun [3 ]
Hong, Sung-Jin [4 ]
Ahn, Chul-Min [5 ]
Ko, Young-Guk [6 ]
Kim, Jung-Sun [5 ]
Choi, Donghoon [7 ]
Hong, Myeong-Ki [8 ]
Jang, Yangsoo [9 ]
Kim, Byeong-Keuk [3 ]
机构：
[1] Wonju Severance Christian Hosp, Wonju, South Korea
[2] Yonsei Univ, Wonju Coll Med, Wonju, South Korea
[3] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea
[4] Yonsei Univ, Severance Hosp, Seoul, South Korea
[5] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Dept Internal Med,Div Cardiol, Seoul, South Korea
[6] Yonsei Univ, Seoul, South Korea
[7] Severance Hosp, Seoul, South Korea
[8] Yonsei Univ, Coll Med, Seoul, South Korea
[9] CHA Univ, CHA Bundang Med Ctr, Sch Med, Bundang, South Korea
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 82卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-249
引用
收藏
页码：B97 / B98
页数：2
相关论文
共 50 条
  • [1] Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation
    Oh, Minyoung
    Kim, Hyunji
    Shin, Eon Woo
    Sung, Changhwan
    Kim, Do-Hoon
    Moon, Dae Hyuk
    Lee, Ji Sung
    Lee, Pil Hyung
    Lee, Seung-Whan
    Lee, Cheol Whan
    MEDICINE, 2021, 100 (10) : E25114
  • [2] Statin and ezetimibe combination therapy in cardiovascular disease
    Dembowski, Ewa
    Davidson, Michael H.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2009, 16 (02) : 183 - 188
  • [3] Remnant cholesterol as a residual risk in atherosclerotic cardiovascular disease patients under statin-based lipid-lowering therapy: A post hoc analysis of the RACING trial
    Lee, Jung-Hee
    Ahn, Sung Gyun
    Jeon, Ho Sung
    Lee, Jun-Won
    Youn, Young Jin
    Lee, Yong-Joon
    Lee, Seung-Jun
    Hong, Sung-Jin
    Ahn, Chul-Min
    Ko, Young-Guk
    Kim, Jung-Sun
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    Kim, Byeong-Keuk
    JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (06) : e905 - e914
  • [4] Lipoprotein(a)-Associated Residual Atherosclerotic Cardiovascular Disease Risk in Patients with Cardiovascular Disease on Statin Therapy by Diabetes Status
    Zhao, Yanglu
    Sung, Jennifer C.
    Browne, Auris
    Wong, Nathan D.
    DIABETES, 2020, 69
  • [5] Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease
    Li, Xi
    Li, Zhi-Fan
    Wu, Na-Qiong
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2025, 26 (02)
  • [6] Statin and Ezetimibe Combination Therapy Decreases Mean Platelet Volume Compared to Statin Monotherapy
    Lee, Jun-beom
    Kim, Gyeong-Seon
    Cho, Han-na
    JOURNAL OF STROKE, 2017, 19 (01) : 109 - 110
  • [7] The Role of HDL Cholesterol in Patients With Atherosclerotic Cardiovascular Disease Under Statin Treatment
    Yi-Heng, Li
    Yin, Wei-Hsian
    Tseng, Wei-Kung
    Lin, Fang-Ju
    Wu, Yen-Wen
    Hsieh, I-Chang
    Lin, Tsung-Hsien
    Sheu, Huey-Herng
    Yeh, Hung-, I
    Chen, Jaw-Wen
    Wu, Chau-Chung
    CIRCULATION, 2018, 138
  • [8] Efficacy of combination therapy with statin and ezetimibe versus high dose statin monotherapy in secondary prevention in high-risk patients
    Halatiu, V. B.
    Benedek, I
    Rodean, I. P.
    Benedek, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [9] Comparison of High-potency Statin Monotherapy and Statin Plus Ezetimibe Combination Therapy for Reducing Cardio-cerebrovascular Disease Risk
    Yang, Bo Ram
    Lee, Joongyub
    Choi, Nam-Kyong
    Shin, Ju-Young
    Chang, Yoosoo
    Song, Hong-Ji
    Youn, KyungEun
    Jin, Xue-Mei
    Kim, Mi-Sook
    Kim, Ye-Jee
    Seong, Jong-Mi
    Park, Byung-Joo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 384 - 385
  • [10] Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial
    Lee, Yong-Joon
    Lee, Sang-Hyup
    You, Seng Chan
    Lee, Yong-ho
    Lee, Seung-Jun
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    Kim, Jung-Sun
    DIABETES OBESITY & METABOLISM, 2024, 26 (03): : 829 - 839
12345